We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 10.8%
3 Consumer Discretionary 9.19%
4 Financials 8.28%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHPT icon
1151
ChargePoint
CHPT
$161M
$486K 0.01%
1,774
+1,294
+270% +$359K
WSFS icon
1152
WSFS Financial
WSFS
$4.15B
$486K 0.01%
12,127
+10,117
+503% +$416K
ILCG icon
1153
iShares Morningstar Growth ETF
ILCG
$3.27B
$485K 0.01%
9,677
+7,926
+453% +$439K
PSI icon
1154
Invesco Semiconductors ETF
PSI
$2.5B
$485K 0.01%
14,892
-4,110
-22% -$151K
FLG
1155
Flagstar Bank National Association
FLG
$5.82B
$484K 0.01%
17,671
+6,653
+60% +$191K
MYGN icon
1156
Myriad Genetics
MYGN
$312M
$483K 0.01%
26,577
+17,032
+178% +$354K
EGP icon
1157
EastGroup Properties
EGP
$10.9B
$482K 0.01%
3,123
+1,005
+47% +$176K
TVTX icon
1158
Travere Therapeutics
TVTX
$5.78B
$481K 0.01%
19,861
+9,171
+86% +$231K
WEX icon
1159
WEX
WEX
$6.31B
$481K 0.01%
3,093
-6,208
-67% -$1.02M
XSMO icon
1160
Invesco S&P SmallCap Momentum ETF
XSMO
$3.1B
$481K 0.01%
10,966
+8,687
+381% +$417K
BLD
1161
DELISTED
TopBuild
BLD
$479K 0.01%
2,865
+1,054
+58% +$193K
CNXC icon
1162
Concentrix
CNXC
$1.57B
$479K 0.01%
3,530
-203
-5% -$30.5K
HOG icon
1163
Harley-Davidson
HOG
$2.71B
$479K 0.01%
15,138
+6,634
+78% +$236K
GBT
1164
DELISTED
Global Blood Therapeutics, Inc.
GBT
$479K 0.01%
14,982
+7,123
+91% +$209K
UNM icon
1165
Unum
UNM
$14.3B
$478K 0.01%
14,049
+2,519
+22% +$85.3K
PII icon
1166
Polaris
PII
$4.07B
$476K 0.01%
4,792
-68
-1% -$7.04K
AXNX
1167
DELISTED
Axonics, Inc. Common Stock
AXNX
$476K 0.01%
8,401
+7,991
+1,949% +$438K
KMPR icon
1168
Kemper
KMPR
$1.68B
$475K 0.01%
9,920
+1,372
+16% +$68.7K
PNQI icon
1169
Invesco NASDAQ Internet ETF
PNQI
$551M
$475K 0.01%
19,870
+14,010
+239% +$383K
ALLY icon
1170
Ally Financial
ALLY
$13.3B
$472K 0.01%
14,081
+4,846
+52% +$194K
ATRC icon
1171
AtriCure
ATRC
$2.11B
$472K 0.01%
11,558
+10,880
+1,605% +$515K
MIDD icon
1172
Middleby
MIDD
$6.08B
$472K 0.01%
3,759
-264
-7% -$38.1K
DOCS icon
1173
Doximity
DOCS
$4.88B
$471K 0.01%
13,553
+12,363
+1,039% +$487K
JNPR
1174
DELISTED
Juniper Networks
JNPR
$471K 0.01%
16,509
-21,758
-57% -$686K
XPH icon
1175
State Street SPDR S&P Pharmaceuticals ETF
XPH
$508M
$471K 0.01%
+11,209
New +$470K

Similar funds

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.